Clinical Trial Update: Sublingual Buprenorphine for Chronic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from NIDA evaluating sublingual buprenorphine for chronic pain. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Sublingual Buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Chronic Pain | Phase 2 | Status: UNKNOWN